Eupraxia Pharmaceuticals Statistics

Total Valuation

TSX:EPRX has a market cap or net worth of CAD 388.60 million. The enterprise value is 306.88 million.

Market Cap	388.60M
Enterprise Value	306.88M

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:EPRX has 50.60 million shares outstanding. The number of shares has increased by 13.21% in one year.

Current Share Class	50.60M
Shares Outstanding	50.60M
Shares Change (YoY)	+13.21%
Shares Change (QoQ)	+2.79%
Owned by Insiders (%)	17.79%
Owned by Institutions (%)	4.92%
Float	38.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	3.15
P/TBV Ratio	4.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.39
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.73

Financial Position

The company has a current ratio of 23.98, with a Debt / Equity ratio of 0.00.

Current Ratio	23.98
Quick Ratio	23.38
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-83.64

Financial Efficiency

Return on equity (ROE) is -61.02% and return on invested capital (ROIC) is -38.47%.

Return on Equity (ROE)	-61.02%
Return on Assets (ROA)	-36.21%
Return on Invested Capital (ROIC)	-38.47%
Return on Capital Employed (ROCE)	-33.60%
Revenue Per Employee	n/a
Profits Per Employee	-1.26M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TSX:EPRX has paid 13,310 in taxes.

Income Tax	13,310
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +76.15% in the last 52 weeks. The beta is 1.49, so TSX:EPRX's price volatility has been higher than the market average.

Beta (5Y)	1.49
52-Week Price Change	+76.15%
50-Day Moving Average	7.90
200-Day Moving Average	6.32
Relative Strength Index (RSI)	46.17
Average Volume (20 Days)	54,120

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-41.44M
Pretax Income	-40.96M
Net Income	-41.51M
EBITDA	-41.16M
EBIT	-41.44M
Earnings Per Share (EPS)	-1.23

Full Income Statement

Balance Sheet

The company has 123.91 million in cash and 237,631 in debt, giving a net cash position of 123.67 million or 2.44 per share.

Cash & Cash Equivalents	123.91M
Total Debt	237,631
Net Cash	123.67M
Net Cash Per Share	2.44
Equity (Book Value)	123.19M
Book Value Per Share	1.61
Working Capital	122.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -34.54 million and capital expenditures -612,817, giving a free cash flow of -35.15 million.

Operating Cash Flow	-34.54M
Capital Expenditures	-612,817
Free Cash Flow	-35.15M
FCF Per Share	-0.69

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:EPRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.21%
Shareholder Yield	-13.21%
Earnings Yield	-10.68%
FCF Yield	-9.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2